Peptide Reports

FOXO4-DRI

Community Protocol

FOXO4-DRI

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 10 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

SetupDiluentConcentrationUnit conversion
10 MG vial – 2 mL exampleAdd 2 mL bacteriostatic water5 mg/mLEach U-100 unit = 50 mcg
10 MG vial – 1 mL exampleAdd 1 mL bacteriostatic water10 mg/mLEach U-100 unit = 100 mcg

Syringe Conversion

Reported amount10 MG setup10 MG setup
1 mg20 units10 units
2.5 mg50 units25 units
5 mg100 units50 units
10 mg200 units100 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring reportFrequency seenContext in reports
2-5 mgIntermittentLower experimental reports
5-10 mgEvery other day in short cyclesSenolytic discussions
Variable mg/kgShort research cyclesHighly inconsistent reports

Observations

  • Community discussions most often centered on senescent-cell and longevity research.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • FOXO4-DRI is highly experimental with no established human safety or dosing standard; senolytic effects could cause unpredictable tissue injury.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. Community search: FOXO4-DRI
  2. PubMed literature search: FOXO4-DRI